Abstract Details

Title Discovery of ARN-6039 as a Potent, Orally Available Inverse Agonist of RORγt for Autoimmune Neuroinflammatory Demyelinating Disease

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 099

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
John W. Rose, MD, FAAN (Imaging and Neurosciences Center) PRESENTER	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Noel Carlson, PhD (VA SLC HCS)	The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Hariprasad Vankayalapati, PhD, CSO (Arrien Pharmaceuticals)	No disclosure on file

��ɫ��